Our laboratory has successfully delivered CRISPR–dCas9 systemically into MCF7 xenografts using dendritic polymers to reactivate the tumor suppressor genes MASPIN and CCN6 in the tumor site, leading to potent and long-lasting cancer growth inhibition [99]. Here, SERPINB5 is linked to neoplasm.